Identification of a novel human estrogen receptor-α splice variant able to enhance malignant biological behaviors of breast cancer cells

Zhu,Hua; Huang,Yue; Su,Heling; Ma,Yili; Tao,Yiming; Liao,D.  Joshua; Liu,Yongming; Feng,Zhenbo

doi:10.3892/ol.2018.7970

Identification of a novel human estrogen receptor-α splice variant able to enhance malignant biological behaviors of breast cancer cells

Authors:
- Hua Zhu
- Yue Huang
- Heling Su
- Yili Ma
- Yiming Tao
- D. Joshua Liao
- Yongming Liu
- Zhenbo Feng
View Affiliations

Affiliations: Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Department of Breast Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, P.R. China, Department of Biotechnology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China, Hormel Institute, The University of Minnesota, Austin, MN 55912, USA
Published online on: February 6, 2018 https://doi.org/10.3892/ol.2018.7970
Pages: 5339-5344

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Since the early 1990s, multiple human estrogen receptor‑α (hER-α) splice variants have been identified, of which the majority contain ≥1 deleted exon, and some are expressed as proteins with modified functions from the wild‑type 66 kDa hER-α (ER‑α66). In the present study, a novel hER‑α splice variant, ER‑α30, was identified and cloned from clinical breast cancer tissue. The ER‑α30 sequence lacked a ligand‑binding domain and a ligand‑dependent transcriptional activation domain but retained the N‑terminal transcriptional activation domain, the DNA‑binding domain and a partial hinge domain, and possesses a unique 10‑amino‑acid domain. The expression of ER‑α30 was associated with ER‑α66‑negative and progesterone receptor‑negative breast cancer. The 30 kDa protein was expressed in stably transfected MDA‑MB‑231 cells, and the overexpression of ER‑α30 in MDA‑MB‑231 cells enhanced malignant biological behaviors, including cellular proliferation, migration and invasion in vitro. The results of the present study indicated that ER‑α30 might represent a potential biomarker for breast cancer.

View Figures

View References

1	Venables JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, Inkel L, Durand M, Couture S, Froehlich U, Lapointe E, et al: Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol. 16:670–676. 2009. View Article : Google Scholar : PubMed/NCBI
2	Chen J and Weiss WA: Alternative splicing in cancer: Implications for biology and therapy. Oncogene. 34:1–14. 2015. View Article : Google Scholar : PubMed/NCBI
3	Ishunina TA and Swaab DF: Estrogen receptor-alpha splice variants in the human brain. Gynecol Endocrinol. 24:93–98. 2008. View Article : Google Scholar : PubMed/NCBI
4	Dunnwald LK, Rossing MA and Li CI: Hormone receptor status, tumor characteristics, and prognosis: A prospective cohort of breast cancer patients. Breast Cancer Res. 9:R62007. View Article : Google Scholar : PubMed/NCBI
5	Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thürlimann B and Senn HJ Panel members: Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 16:1569–1583. 2005. View Article : Google Scholar : PubMed/NCBI
6	Huang B, Warner M and Gustafsson JÅ: Estrogen receptors in breast carcinogenesis and endocrine therapy. Mol Cell Endocrinol. 418(Pt 3): 1–244. 2015.PubMed/NCBI
7	Li G, Zhang J, Jin K, He K, Zheng Y, Xu X, Wang H, Wang H, Li Z, Yu X, et al: Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells. Mol Oncol. 7:611–624. 2013. View Article : Google Scholar : PubMed/NCBI
8	Penot G, Le Péron C, Mérot Y, Grimaud-Fanouillère E, Ferrière F, Boujrad N, Kah O, Saligaut C, Ducouret B, Métivier R and Flouriot G: The human estrogen receptor-alpha isoform hERalpha46 antagonizes the proliferative influence of hERalpha66 in MCF7 breast cancer cells. Endocrinology. 146:5474–5484. 2005. View Article : Google Scholar : PubMed/NCBI
9	Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF and Bast RC Jr; American Society of Clinical Oncology, : American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 25:5287–5312. 2007. View Article : Google Scholar : PubMed/NCBI
10	Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, et al: Revision of the american joint committee on cancer staging system for breast cancer. J Clin Oncol. 20:3628–3636. 2002. View Article : Google Scholar : PubMed/NCBI
11	Denger S, Reid G, Kos M, Flouriot G, Parsch D, Brand H, Korach KS, Sonntag-Buck V and Gannon F: ERalpha gene expression in human primary osteoblasts: Evidence for the expression of two receptor proteins. Mol Endocrinol. 15:2064–2077. 2001. View Article : Google Scholar : PubMed/NCBI
12	Li L, Haynes MP and Bender JR: Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA. 100:pp. 4807–4812. 2003; View Article : Google Scholar : PubMed/NCBI
13	Wang Z, Zhang X, Shen P, Loggie BW, Chang Y and Deuel TF: Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun. 336:1023–1027. 2005. View Article : Google Scholar : PubMed/NCBI
14	Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, Sonntag-Buck V and Gannon F: Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J. 19:4688–4700. 2000. View Article : Google Scholar : PubMed/NCBI
15	Márquez DC and Pietras RJ: Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene. 20:5420–5430. 2001. View Article : Google Scholar : PubMed/NCBI
16	Parl FF, Schmidt BP, Dupont WD and Wagner RK: Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading. Cancer. 54:2237–2242. 1984. View Article : Google Scholar : PubMed/NCBI